Efficacy and Safety of Avanafil in Chinese Subjects With Erectile Dysfunction: A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial

Introduction: The incidence of erectile dysfunction (ED) increases with age in mainland China and phosphodiesterase 5 inhibitors (PDE5i) are the major drugs used for its treatment. Aim: To determine the efficacy and safety of Chinese developed avanafil as therapy for ED in China. Methods: This phase...

Full description

Bibliographic Details

Published in:	Sexual Medicine
Main Authors:	Hui Jiang, MD, PhD, Haocheng Lin, MD, PhD, Fubiao Li, MD, Yutian Dai, MD, PhD, Xiangsheng Zhang, MD, PhD, Tao Jiang, MD, PhD, Junhong Deng, MD, PhD
Format:	Article
Language:	English
Published:	Oxford University Press 2021-06-01
Subjects:	Avanafil Erectile Dysfunction Efficacy Safety Phase III Trial
Online Access:	http://www.sciencedirect.com/science/article/pii/S2050116121000179